Berkshire Hathaway, 3G Capital close $28 billion Heinz deal
PITTSBURGH – Warren Buffett’s Berkshire Hathaway and 3G have completed their acquisition of condiment maker H.J. Heinz Co., Heinz said.
Shareholders of Heinz will receive $72.50 per share in cash in the sale, whose total price is $28 billion. As a result of the deal, Heinz’s stock is no longer trading on the New York Stock Exchange, and 3G Capital partner Bernardo Hees has been appointed as CEO.
"I look forward to building upon Heinz’s incredible platform and delivering world-class products for all of our consumers around the world, while maintaining the company’s unwavering commitment to quality, safety and superior customer service," Hees said.
Nivea Men brings consumer insights to life with new campaign
WILTON, Conn. — Beiersdorf’s Nivea Men has developed the Silence the Irritation campaign to help educate men on the role that skin care plays in providing a comfortable shave.
To help bring this campaign to life, the brand partnered with digital media company Break Media to launch a multi-layered campaign. Utilizing Break Media’s Acumen research platform, the teams surveyed more than 1,000 men to find out where shaving ranked on a list of day-to-day life irritations. The results revealed that most men find having to shave, along with the resulting razor burn and irritation, as their biggest day-to-day irritants. These findings also laid the groundwork for the “Silence the Irritation” campaign, which includes a branded Nivea Men hub on Break Media’s online men’s lifestyle platform MadeMan.com, as well as the launch of an eight-episode comedy series titled, “Just Face It.”
To help gain interest and resonate with the target consumer, the men’s grooming brand and Break Media enlisted Damon Wayans, Jr. “Just Face It,” which follows Wayans’ character through day-to-day irritations based on the survey findings, premiered May 7 and wrapped this past week.
In addition to housing each episode of the “Just Face It” series, the branded hub features Nivea Men Sensitive products to correlate with “silencing the irritation” of shaving, editorial content created with the Nivea Men target in mind and relevantly themed sweepstake opportunities.
According to the manufacturer, the branded series proved successful for Nivea Men:
- More than 3 million video views were generated on behalf of the series;
- More than 130 million consumers touched via dedicated public relations outreach helped drive people to the branded hub and series videos;
- PR targeted B2B, industry and consumer media outlets;
- Across social media, the campaign generated more than 25,000 “likes” on its dedicated Facebook page;
- More than 5,200 mentions of the “Silence the Irritation” campaign across Twitter;
- 740,000 total user interactions with the videos (across YouTube, Twitter and Facebook);
- The Nivea Men-branded hub on MadeMan.com showed strong engagement across multiple metrics;
- It received more than 270,000 page views; and
Visitors spent more than three minutes on the page.
Concern about birth defects shouldn’t stop women from taking mental health drugs, experts say
NEW YORK – Pregnant women taking drugs for mental health problems should not stop taking their drugs without first talking to their doctors, experts say.
At a recent luncheon sponsored by the March of dimes National Communications Advisory Council, experts said more than half of pregnant women take at least one prescription drug at some time during pregnancy, and some young women have been taking drugs to treat such conditions as depression, anxiety and attention deficit hyperactivity disorder since they were teenagers. Women taking these drugs should seek support and guidance from healthcare providers to determine if they should continue or switch to another drug.
"Pregnant women should talk to their doctor about which medications they are taking and what are the best options for them while pregnant," Yale University School of Medicine post-menopausal syndrome and perinatal psychiatric research program director Kimberly Yonkers said. "It is important to balance the possible risks and benefits of all medications to the mother and the baby."